Medical Parasitology and Infection Biology
MPI NewsAll News
Jennifer Keiser, Head of the Helminth Drug Development Unit at Swiss TPH, was awarded a European Research Council Advanced Grant for EUR 2.47 million over five years to conduct... More...
Strongyloidiasis, a parasitic worm infection caused by soil-transmitted helminths, remains a neglected public health problem with limited treatment options. Swiss TPH researchers... More...
A new study reveals that it is possible to identify those individuals that will be protected by the malaria vaccine before its administration. The researchers also found that... More...
Latest MPI PublicationsAll Publications
Alagna R et al. Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?. Eur Respir J. 2021;58:2100959. DOI: 10.1183/13993003.00959-2021
Arafa R.K et al. New antiparasitic flexible triaryl diamidines, their prodrugs and aza analogues: synthesis, in vitro and in vivo biological evaluation, and molecular modelling studies. Eur J Med Chem. 2021;222:113625. DOI: 10.1016/j.ejmech.2021.113625
Asare P et al. Genomic epidemiological analysis identifies high relapse among individuals with recurring tuberculosis and provides evidence of household recent TB transmission in Ghana. Int J Infect Dis. 2021;106:13-22. DOI: 10.1016/j.ijid.2021.02.110
Assaré R.K et al. Accuracy of two circulating antigen tests for the diagnosis and surveillance of Schistosoma mansoni infection in low-endemicity settings of Côte d'Ivoire. Am J Trop Med Hyg. 2021(in press)
Bärenbold O et al. Estimating true prevalence of Schistosoma mansoni from population summary measures based on the Kato-Katz diagnostic technique. PLoS Negl Trop Dis. 2021;15(4):e0009310. DOI: 10.1371/journal.pntd.0009310